V. Rodriguez
About
In The Last Decade
V. Rodriguez
15 papers receiving 346 citations
Peers
Comparison fields: 5 of 61
- Oncology 162
- Hematology 118
- Pulmonary and Respiratory Medicine 111
- Public Health, Environmental and Occupational Health 64
- Molecular Biology 60
Countries citing papers authored by V. Rodriguez
This map shows the geographic impact of V. Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Rodriguez more than expected).
Fields of papers citing papers by V. Rodriguez
This network shows the impact of papers produced by V. Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Rodriguez. The network helps show where V. Rodriguez may publish in the future.
Co-authorship network of co-authors of V. Rodriguez
This figure shows the co-authorship network connecting the top 25 collaborators of V. Rodriguez. A scholar is included among the top collaborators of V. Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Rodriguez. V. Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 38 | |
| 8 | Improvement of liver mass function in cirrhotic animals by hepatocellular transplantation. | 2 |
| 9 | Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia. | 7 |
| 10 | 8 | |
| 11 | Chemoimmunotherapy of advanced non Hodgkin's lymphoma (NHL) with CHOP Bleo + levamisole | 5 |
| 12 | 2 | |
| 13 | Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. | 114 |
| 14 | Prognostic factors in acute leukemia. | 99 |
| 15 | 29 | |
| 16 | 25 | |
| 17 | Treatment of acute leukemia with 5-azacytidine (NSC-102816). | 43 |
| 18 | Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271). | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.